Hepatitis C virus non-structural proteins (HCV NS proteins)

The Hepatitis C virus (HCV) non-structural proteins (NS2, NS3, NS4A, NS4B, NS5A, and NS5B) are essential components of the viral replication machinery, produced through the proteolytic cleavage of a single polyprotein (UniProt: P26664). These proteins perform diverse enzymatic and structural roles: NS3/4A functions as a serine protease and helicase, NS5B acts as the RNA-dependent RNA polymerase responsible for genome replication, and NS5A is a multifunctional phosphoprotein critical for viral assembly and modulating host immune responses (PubMed: 23943486). In chronic infection, these proteins facilitate persistent viral replication, leading to progressive liver inflammation, cirrhosis, and an increased risk of hepatocellular carcinoma (WHO: Hepatitis C Fact Sheet). They are the primary targets for direct-acting antivirals (DAAs), which have transformed HCV therapy by providing high cure rates across various genotypes (PubMed: 26898445). Modern treatment strategies typically utilize combinations of NS3/4A, NS5A, and NS5B inhibitors to maximize efficacy and prevent the development of drug resistance (AASLD-IDSA HCV Guidance).

Other names

HCV non-structural proteinsHCV NS2-NS5BHepatitis C virus nonstructural proteinsHCV encoded antigensHCV replication complex proteins

Inhibition of the NS3/4A serine protease to prevent polyprotein cleavage; inhibition of the NS5A protein to disrupt viral replication complex assembly and signaling; and inhibition of the NS5B RNA-dependent RNA polymerase to terminate viral RNA synthesis.